Merck’s north London pick for discovery center could accelerate growth of surrounding research hub

Merck’s selection of a north London site for its newest Discovery Research Centre should accelerate what is becoming a growing and densely populated hub of biomedical research. 

Merck & Co. Inc. (NYSE:MRK) this week unveiled its plans to invest about £1 billion ($1.3 billion) to build the center and its U.K. headquarters near the King’s Cross and St. Pancras International railway stations...